Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
716.35
69.85 (10.8%)
BSENSE

Apr 29

BSE+NSE Vol: 24.34 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLincoln Pharma. VS Pharmaceuticals & Biotechnology
 
1D
10.8%
1.39%
1W
17.53%
-0.72%
1M
22.29%
5.94%
YTD
48.25%
-8.53%
1Y
23.08%
-2.91%
3Y
82.63%
27.56%
5Y
162.16%
56.64%
10Y
364.86%
204.43%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.28%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
60.78%
0%
60.78%
6 Months
34.99%
0%
34.99%
1 Year
23.08%
0.32%
23.4%
2 Years
20.46%
0.33%
20.79%
3 Years
82.63%
0.86%
83.49%
4 Years
117.64%
1.69%
119.33%
5 Years
162.16%
2.13%
164.29%

Latest dividend: 1.8 per share ex-dividend date: Sep-12-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Underperformer

Lincoln Pharmaceuticals Ltd has been in the Third and Fourth Quartile in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
14.56%
1
Quartile
quartile-1
Dec-Mar
16.79%
3
Quartile
quartile-3
Sep-Dec
-9.23%
3
Quartile
quartile-3
1Y
11.08%
4
Quartile
quartile-4
2025
-38.91%
3
Quartile
quartile-3
2024
29.85%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
14.56%
1
Quartile
quartile-1
Dec-Mar
16.79%
3
Quartile
quartile-3
Sep-Dec
-9.23%
2
Quartile
quartile-2
1Y
11.08%
4
Quartile
quartile-4
2025
-38.91%
3
Quartile
quartile-3
2024
29.85%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
14.56%
1
Quartile
quartile-1
Dec-Mar
16.79%
3
Quartile
quartile-3
Sep-Dec
-9.23%
2
Quartile
quartile-2
1Y
11.08%
4
Quartile
quartile-4
2025
-38.91%
2
Quartile
quartile-2
2024
29.85%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available